Australia Patent for 'Recombinant antibodies and fragments recognising ganglioside N-glycolyl-gm3 and use thereof in the diagnosis and treatment of tumours' Ceases

Press/Media

Period17 Nov 2023

Media coverage

1

Media coverage

  • TitleAustralia Patent for 'Recombinant antibodies and fragments recognising ganglioside N-glycolyl-gm3 and use thereof in the diagnosis and treatment of tumours' Ceases
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date17/11/23
    PersonsErnesto Moreno Frías